mutation in the NF1 gene
Showing 1 - 25 of 9,495
Cancer, Cancer Metastatic, BRAF V600E Trial in Indianapolis (Abemaciclib, LY3214996)
Recruiting
- Cancer
- +6 more
-
Indianapolis, IndianaIndiana University Hospital / IU Simon Cancer Center
Jan 12, 2023
Hematologic Malignancy, Acute Leukemia, Remission Trial (Fludarabine, Busulfan, Melphalan)
Not yet recruiting
- Hematologic Malignancy
- +21 more
- Fludarabine
- +4 more
- (no location specified)
Feb 9, 2023
An Intervention to Increase Genetic Testing in Families Who May
Recruiting
- BRCA1 Mutation
- +21 more
- Intervention Arm At-risk Relative/ARR Contacts
- +5 more
-
Basking Ridge, New Jersey
- +7 more
Nov 22, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Negative Breast Carcinoma, Metastatic Hormone Receptor-Positive Breast
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +2 more
- Binimetinib
- +5 more
- (no location specified)
Nov 8, 2022
Slow-Flow Vascular Malformation, Fast-Flow Vascular Malformation, Vascular Malformations Trial in Parkville (Alpelisib,
Not yet recruiting
- Slow-Flow Vascular Malformation
- +17 more
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital
Aug 7, 2023
Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)
Not yet recruiting
- Leber Hereditary Optic Neuropathy (LHON)
- NFS-02 Injection
- (no location specified)
Apr 6, 2023
ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,
Recruiting
- ATM Gene Mutation
- +16 more
- Niraparib
- +2 more
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Oct 27, 2022
Metastatic Solid Tumor, SF3B1 Gene Mutation, Spliceosome Mutation Trial in Baltimore (Recommendation for treatment with
Recruiting
- Metastatic Solid Tumor
- +4 more
- Recommendation for treatment with immunotherapy
-
Baltimore, MarylandJohns Hopkins University
Sep 8, 2022
Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,
Recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)
Not yet recruiting
- Metastatic Solid Tumor
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 12, 2023
Trial
Not yet recruiting
- Leber Hereditary Optic Neuropathy (LHON)
- NR082 Injection
- Injection needle
- (no location specified)
Jan 30, 2023
Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)
Suspended
- Solid Tumor
- ARID1A Gene Mutation
-
Greenville, South CarolinaPrisma Health Cancer Institute
Jan 10, 2023
The Prevelence of IVS 1-6 [HBB:c.92 +6 T-C] Gene Mutation in
Not yet recruiting
- Beta-Thalassemia
- ARMS
- (no location specified)
May 10, 2022
MEN1 Gene Mutation Trial in Basel (Leflunomide 20 mg)
Not yet recruiting
- MEN1 Gene Mutation
- Leflunomide 20 mg
-
Basel, SwitzerlandUnispital Basel
Nov 1, 2022
BARD1 Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Houston, Seattle (Educational Intervention, Genetic
Recruiting
- BARD1 Gene Mutation
- +14 more
- Educational Intervention
- +3 more
-
Houston, Texas
- +1 more
Jun 14, 2022
Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)
Not yet recruiting
- Prostate Cancer
- +4 more
- Olaparib
- LHRH agonist
- (no location specified)
Aug 10, 2022
RAS Mutation, Neurofibromatosis 1, Noonan Syndrome Trial in Cincinnati
Recruiting
- RAS Mutation
- +13 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Feb 24, 2022
Factors Influencing Cascade Testing Among Hereditary
Recruiting
- Breast Carcinoma
- +8 more
- Interview
- +2 more
-
Birmingham, Alabama
- +1 more
Jun 22, 2022
Hyperekplexia in Patients With CTNNB1 Mutation
Not yet recruiting
- Hyperekplexia
- CTNNB1 Gene Mutation
- Questionnaire
- (no location specified)
Feb 11, 2022
Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)
Active, not recruiting
- Breast Cancer
- +3 more
-
Boston, Massachusetts
- +2 more
Dec 21, 2022